RJA
SNV

Raymond James & Associates’s Synovus SNV Stock Holding History

Raymond James & Associates’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-42,900
Closed -$32.2K – 4055
2022
Q4 		$32.2K Sell
42,900
-1,200
-3% -$47.6K ﹤0.01% 3753
2022
Q3 		$11K Hold
44,100
– – ﹤0.01% 3855
2022
Q2 		$13K Buy
+44,100
New +$1.82M ﹤0.01% 3918

Other funds holding SNV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Raymond James & Associates's SNV Position: Q3 2024 in Review

Raymond James & Associates reduced its Synovus (SNV) stake by 7.5% in Q3 2024, selling an estimated $379K and leaving 106,355 shares worth $4.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

Raymond James & Associates first reported a position in SNV in Q2 2013 and has held it in 46 quarters since. The position peaked at $16M in Q4 2021. 433 funds tracked by Wall St. Rank hold SNV as of Q3 2024.

  • Raymond James & Associates held 106,355 shares of Synovus worth $4.73M as of Q3 2024.
  • Raymond James & Associates sold 8,658 Synovus shares in Q3 2024, an estimated $379K.
  • Synovus made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1688 holding.
  • Raymond James & Associates first reported a position in Synovus in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Synovus position peaked at $16M in Q4 2021.
  • 433 funds tracked by Wall St. Rank held Synovus as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.